WARNING
Keep out of eyes.
OTC - STOP USE SECTION
Stop use if irritation occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
Keep out of eyes.
Stop use if irritation occurs.
Keep out of reach of children
TITANIUM DIOXIDE 6.40% • ZINC OXIDE 2.00%
WATER • TRIOCTYLDODECYL CITRATE • CYCLOPENTASILOXANE • BUTYLENE GLYCOL • C12-15 ALKYL BENZOATE • STEARETH-2 • STEARYL DIMETHICONE • TRICAPRYLYL CITRATE • SILICA • BARIUM SULFATE • SORBITAN TRISTEARATE • ALUMINUM STEARATE • ASCOPHYLLUM NODOSUM EXTRACT • ASPARAGOPSIS ARMATA EXTRACT • LECITHIN • SEA WHIP EXTRACT • GLYCERYL STEARATE • TOCOPHERYL ACETATE • PEG-100 STEARATE • SUCROSE • PANTETHINE • CAFFEINE • OCTYLDODECYL NEOPENTANOATE • CETETH-2 • PEG-40 STEARATE • DIMETHICONE • CETEARYL ALCOHOL • PEG/PPG-18/18 DIMETHICONE • STEARETH-20 • BISABOLOL • MAGNESIUM ASCORBYL PHOSPHATE • POLYGLYCERYL-6 POLYRICINOLEATE • SORBITOL • PHYTOSPHINGOSINE • SODIUM STEARATE • MAGNESIUM ALUMINUM SILICATE • CAPRYLYL GLYCOL • ISOPROPYL TITANIUM TRIISOSTEARATE • STEARIC ACID • HEXYLENE GLYCOL • XANTHAN GUM • DISODIUM EDTA • PHENOXYETHANOL • IRON OXIDES (CI 77491, CI 77492, CI 77499) • CHROMIUM HYDROXIDE GREEN (CI 77289) [ILN36209]
© CLINIQUE LABORATORIES, DIST.
NEW YORK, N.Y. 10022
CLINIQUE
redness
solutions
daily
protective base
SPF 15
ALL SKIN TYPES
1.35 FL.OZ.LIQ./40 ml e
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49527-722-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1378-f424-e053-dadaa90a57ce | CLINIQUE redness solutions |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49527-722-01 | CLINIQUE REDNESS SOLUTIONS DAILY PROTECTIVE BASE SPF 15 | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 49527-722-01 | CLINIQUE REDNESS SOLUTIONS DAILY PROTECTIVE BASE SPF 15 | 40 mL in 1 BOTTLE | CREAM | 40 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| alkyl (c12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| alpha-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| aluminum stearate | INACTIVE INGREDIENT | U6XF9NP8HM | 1 | |
| ascophyllum nodosum | INACTIVE INGREDIENT | 168S4EO8YJ | 1 | |
| asparagopsis armata | INACTIVE INGREDIENT | 2936KN6I1G | 1 | |
| barium sulfate | INACTIVE INGREDIENT | 25BB7EKE2E | 1 | |
| butylene glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| caffeine | INACTIVE INGREDIENT | 3G6A5W338E | 1 | |
| caprylyl glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| ceteth-2 | INACTIVE INGREDIENT | 7H8VAM7778 | 1 | |
| cetostearyl alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| hexylene glycol | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| levomenol | INACTIVE INGREDIENT | 24WE03BX2T | 1 | |
| magnesium aluminum silicate | INACTIVE INGREDIENT | 6M3P64V0NC | 1 | |
| magnesium ascorbyl phosphate | INACTIVE INGREDIENT | 0R822556M5 | 1 | |
| octyldodecyl neopentanoate | INACTIVE INGREDIENT | X8725R883T | 1 | |
| pantethine | INACTIVE INGREDIENT | 7K81IL792L | 1 | |
| peg-100 stearate | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| peg-40 stearate | INACTIVE INGREDIENT | ECU18C66Q7 | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| pseudopterogorgia elisabethae | INACTIVE INGREDIENT | UDY3H1OUX5 | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| sodium stearate | INACTIVE INGREDIENT | QU7E2XA9TG | 1 | |
| sorbitan tristearate | INACTIVE INGREDIENT | 6LUM696811 | 1 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | 1 | |
| steareth-2 | INACTIVE INGREDIENT | V56DFE46J5 | 1 | |
| steareth-20 | INACTIVE INGREDIENT | L0Q8IK9E08 | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 | |
| tricaprylyl citrate | INACTIVE INGREDIENT | BXW1GAI4TA | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| xanthan gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49527-722 | 49527-722-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| peg-100 stearate | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| xanthan gum | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| sorbitol | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| sorbitol | SORBITOL | 506T60A25R | CREAM / TOPICAL | 36.8 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| xanthan gum | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| xanthan gum | XANTHAN GUM | TTV12P4NEE | GEL / TOPICAL | 58 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, DELAYED RELEASE / ORAL | 7 mg | ||
| sorbitol | SORBITOL | 506T60A25R | PASTE, DENTIFRICE / DENTAL | 14 %w/w | ||
| aluminum stearate | ALUMINUM STEARATE | U6XF9NP8HM | CAPSULE, EXTENDED RELEASE / ORAL | 1 mg | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| sodium stearate | SODIUM STEARATE | QU7E2XA9TG | TABLET / ORAL | 9.48 mg | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / SUBLINGUAL | 1 mg | ||
| ferrosoferric oxide | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, EXTENDED RELEASE / ORAL | 1.49 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | GRANULE, FOR SUSPENSION / ORAL | 4 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| barium sulfate | BARIUM SULFATE | 25BB7EKE2E | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 10 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | SUSPENSION, EXTENDED RELEASE / ORAL | 2.7 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| sorbitol | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / ORAL | 432 mg | ||
| xanthan gum | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SOLUTION / ORAL | 10 mg/5ml | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| barium sulfate | BARIUM SULFATE | 25BB7EKE2E | IMPLANT / SUBCUTANEOUS | 15 mg | ||
| hexylene glycol | HEXYLENE GLYCOL | KEH0A3F75J | CREAM / TOPICAL | 385 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / TOPICAL | 836 mg | ||
| aluminum stearate | ALUMINUM STEARATE | U6XF9NP8HM | TABLET / ORAL | 6 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| magnesium aluminum silicate | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | TABLET, EXTENDED RELEASE / ORAL | 70 mg | ||
| sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRAMUSCULAR | NA | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1.04 %w/v | ||
| sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| aluminum stearate | ALUMINUM STEARATE | U6XF9NP8HM | TABLET, EXTENDED RELEASE / ORAL | 105 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, EMULSION / INTRAVENOUS | 59 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| xanthan gum | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | POWDER / RESPIRATORY (INHALATION) | 0.04 mg | ||
| sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f22e64e9-8b07-4af1-9bbc-1978bf835562 | cf49d7f3-01d8-490c-b9a4-ff69aee1e183 | 2011-12-01 | Warnings | f22e64e9-8b07-4af1-9bbc-1978bf835562 cf49d7f3-01d8-490c-b9a4-ff69aee1e183 |
Adverse event summaries are temporarily unavailable. Other product information remains available.